BeStock  
Stocks › Biotechnology › INSM

Insmed INSM

US equityMarket cap rank #510Biotechnology
$110.61 −$3.53 (-3.09%)
Market open · Oct 1, 11:50 am ET · After hours $115.68 +1.35%
Open$114.51
Prev close$114.14
Day range$109.71 – $116.18
Volume708.2K
Market cap$24.16B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts20
Average target$198.21+79.2% vs. price
  • Buy 100%
Low $169.00Now $110.61Avg $198.21High $243.00

Recent rating changes

The last 20 actions on file set price targets from $170.00 to $220.00, averaging $199.75.

DateFirmRatingTarget
30 Sep 2026 Barclays BUY $207.00
28 Sep 2026 J.P. Morgan BUY $175.00
25 Sep 2026 Morgan Stanley BUY $218.00
24 Sep 2026 Goldman Sachs BUY $188.00
22 Sep 2026 Mizuho Securities BUY $195.00
21 Sep 2026 BofA Securities BUY $214.00
18 Sep 2026 Morgan Stanley BUY $218.00
15 Sep 2026 Roth MKM BUY $198.00
11 Sep 2026 Morgan Stanley BUY $218.00
25 Aug 2026 RBC Capital BUY $195.00
24 Aug 2026 Mizuho Securities BUY $195.00
24 Aug 2026 Morgan Stanley BUY $218.00
17 Aug 2026 BMO Capital BUY $192.00
14 Aug 2026 Morgan Stanley BUY $218.00
10 Aug 2026 Truist Financial BUY $195.00
10 Aug 2026 H.C. Wainwright BUY $220.00
10 Aug 2026 J.P. Morgan BUY $175.00
7 Aug 2026 UBS BUY $172.00
7 Aug 2026 BofA Securities BUY $214.00
7 Aug 2026 Evercore BUY $170.00

Discussion

No comments yet — be the first to weigh in on INSM.

Leave a comment

Scroll to Top